XBI vs. VOO
XBI (SPDR S&P Biotech ETF) and VOO (Vanguard S&P 500 ETF) are both exchange-traded funds - XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while VOO is a S&P 500 fund tracking the S&P 500 Index. Both are passively managed. Over the past 10 years, XBI returned 11.06%/yr vs 15.77%/yr for VOO. A 0.58 correlation means they provide meaningful diversification when combined. XBI charges 0.35%/yr vs 0.03%/yr for VOO.
Performance
XBI vs. VOO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBI achieves a 19.74% return, which is significantly higher than VOO's 9.75% return. Over the past 10 years, XBI has underperformed VOO with an annualized return of 11.06%, while VOO has yielded a comparatively higher 15.77% annualized return.
XBI
- 1D
- 3.75%
- 1M
- 10.89%
- YTD
- 19.74%
- 6M
- 15.96%
- 1Y
- 77.88%
- 3Y*
- 19.92%
- 5Y*
- 1.79%
- 10Y*
- 11.06%
VOO
- 1D
- -0.29%
- 1M
- 0.08%
- YTD
- 9.75%
- 6M
- 9.30%
- 1Y
- 26.77%
- 3Y*
- 21.36%
- 5Y*
- 13.58%
- 10Y*
- 15.77%
XBI vs. VOO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBI SPDR S&P Biotech ETF | 19.74% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
VOO Vanguard S&P 500 ETF | 9.75% | 17.82% | 24.98% | 26.32% | -18.17% | 28.79% | 18.32% | 31.37% | -4.50% | 21.77% |
Correlation
The correlation between XBI and VOO is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.57 |
Correlation (All Time) Calculated using the full available price history since Sep 9, 2010 | 0.58 |
The correlation between XBI and VOO has been stable across timeframes, ranging from 0.50 to 0.58 - a consistent structural relationship.
XBI vs. VOO - Sectors Allocation Comparison
Sectors
XBI
VOO
Healthcare
Financial Services
Basic Materials
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
XBI
VOO
Financial Services
XBI
VOO
Basic Materials
XBI
VOO
Communication Services
XBI
-
VOO
Consumer Cyclical
XBI
-
VOO
Consumer Defensive
XBI
-
VOO
Energy
XBI
-
VOO
Industrials
XBI
-
VOO
Real Estate
XBI
-
VOO
Technology
XBI
-
VOO
Utilities
XBI
-
VOO
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBI vs. VOO — Risk / Return Rank
XBI
VOO
XBI vs. VOO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XBI | VOO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.78 | ||
| Sortino ratioReturn per unit of downside risk | +0.90 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.39 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 8.05 | 3.02 | +5.03 |
| Martin ratioReturn relative to average drawdown | 23.79 | 13.58 | +10.21 |
Loading charts...
Drawdowns
XBI vs. VOO - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for XBI and VOO.
Loading charts...
Drawdown Indicators
| XBI | VOO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.89% | -33.99% | -29.90% |
Max Drawdown (1Y)Largest decline over 1 year | -9.72% | -8.90% | -0.82% |
Max Drawdown (3Y)Largest decline over 3 years | -32.99% | -18.69% | -14.30% |
Max Drawdown (5Y)Largest decline over 5 years | -54.71% | -24.52% | -30.19% |
Max Drawdown (10Y)Largest decline over 10 years | -63.89% | -33.99% | -29.90% |
Current DrawdownCurrent decline from peak | -15.61% | -1.74% | -13.87% |
Average DrawdownAverage peak-to-trough decline | -20.93% | -3.68% | -17.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.28% | 1.98% | +1.30% |
Volatility
XBI vs. VOO - Volatility Comparison
SPDR S&P Biotech ETF (XBI) has a higher volatility of 9.97% compared to Vanguard S&P 500 ETF (VOO) at 4.60%. This indicates that XBI's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XBI | VOO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.97% | 4.60% | +5.37% |
Volatility (6M)Calculated over the trailing 6-month period | 21.32% | 9.73% | +11.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.52% | 12.39% | +14.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.30% | 16.90% | +15.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.04% | 18.05% | +13.99% |
XBI vs. VOO - Expense Ratio Comparison
XBI has a 0.35% expense ratio, which is higher than VOO's 0.03% expense ratio.
Dividends
XBI vs. VOO - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.40%, less than VOO's 1.04% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VOO Vanguard S&P 500 ETF | 1.04% | 1.13% | 1.24% | 1.46% | 1.69% | 1.25% | 1.54% | 1.88% | 2.06% | 1.78% | 2.02% | 2.10% |
XBI SPDR S&P Biotech ETF | 0.40% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
XBI and VOO have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (9.97%) compared to VOO (4.60%). In terms of maximum drawdown, XBI dropped -63.89% vs VOO's -33.99%.
On 10-year performance, VOO leads with 15.77% vs 11.06% for XBI. On fees, VOO is cheaper at 0.03% per year. On volatility, VOO has been the lower-risk option at 4.60%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, VOO has performed better with a 15.77% return vs 11.06%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VOO is cheaper with a 0.03% expense ratio, compared with 0.35% for XBI.
VOO has the higher dividend yield at 1.04%, compared with 0.40% for XBI.
XBI is categorized as Health & Biotech Equities, while VOO is S&P 500. XBI tracks S&P Biotechnology Select Industry Index, while VOO tracks S&P 500 Index. They also come from different issuers: State Street and Vanguard. Their fees differ too: 0.35% for XBI and 0.03% for VOO.
XBI currently has the higher Sharpe Ratio (2.96 vs 2.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XBI and VOO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer